Welcome to the MedLibrary.org Wikipedia Supplement on Therapeutic hypothermia -- Please Click to Return to Front Page

This article may require cleanup to meet Wikipedia's quality standards. Please improve this article if you can. (August 2008)

The tone or style of this article or section may not be appropriate for Wikipedia. Specific concerns may be found on the talk page. See Wikipedia's guide to writing better articles for suggestions. (August 2008)

Therapeutic hypothermia is a medical treatment method which clinically uses the advantages of a lower body temperature. Therapeutic hypothermia is the only way to treat revived (i.e. resuscitated) cardiac arrest victims. The new treatment method is able to reduce mortality of succesfully resuscitated cardiac arrest victims by 35 percent, while it significantly increases the chance of a good neurologic outcome by 39 percent. Every sixth time a cardiac arrest patient is treated with therapeutic hypothermia, physicians can rescue one life. As cardiac arrest is the most common cause of death in the industrialized world, therapeutic hypothermia has the power to save an enormous number of patients.

However, there exists a growing body of evidence that hypothermia increases survival chances and quality for patients suffering from other ischemic insults such as stroke or generalized brain trauma. Hypothermia is also believed to be effective in fever management and in many other medical areas.

Contents 1 History 2 Types of ischemic events 2.1 Cardiac arrest 2.2 Stroke 2.3 Fever 3 Cellular mechanism 4 Mechanics 5 Methods 5.1 Invasive 5.1.1 Cooling catheters 5.2 Non-invasive 5.2.1 Water blankets 5.2.2 Arctic Sun 6 Conclusion 7 See also 8 External links 9 Notes

History

Hypothermia has been applied therapeutically since antiquity. The Roman citizen Hippocrates, the namesake of the Hippocratic Oath and arguably the world’s first modern doctor, advocated the packing of wounded soldiers in snow and ice.^[1] Napoleonic surgeon Baron Dominque Larrey recorded that officers, who were kept closer to the fire, survived less often than the minimally pampered infantrymen.^[1] In modern times the first medical article concerning hypothermia was published in 1945.^[1]This study focused on the effects of hypothermia on patients suffering from severe head injury. In the 1950’s hypothermia received its first medical application, being used in intracerebal aneurysm surgery to create a bloodless field. ^[1] Most of the early research focused on the applications of deep hypothermia, defined as a body temperature between 20-25 °C (68-77 °F). Such an extreme drop in body temperature brings with it a whole host of side effects, side effects which made the use of deep hypothermia impractical in most clinical situations.

This period also saw sporadic investigation of more mild forms of hypothermia, with mild hypothermia being define as a body temperature between 32-34°C (89.6-93.2°F). In the 1950’s Doctor Rosomoff demonstrated in dogs the positive effects of mild hypothermia after brain ischemia and traumatic brain injury.^[1] In the 1980’s further animal studies indicated the ability of mild hypothermia to act as a general neuroprotectant following a blockage of blood flow to the brain.^[1] Responding to this research, in 2003 the American Heart Association (AHA) and the International Liaison Committee on Resuscitation (ILCOR) endorsed the use of therapeutic hypothermia following cardiac arrest.^[2] Currently, a growing percentage of hospitals around the world incorporate the AHA/ILCOR guidelines and include hypothermic therapies in their standard package of care for patients suffering from cardiac arrest. Some researchers go so far as to contend that hypothermia represents a better neuroprotectant following a blockage of blood to the brain than any known drug.^[3]

Types of ischemic events

The types of medical events hypothermic therapies may effectively treat fall into three primary categories: cardiac arrest, ischemic stroke, and neurogenic fever following brain trauma.

Cardiac arrest

The data concerning hypothermia’s neuroprotectant qualities following cardiac arrest can be best summarized by two studies published in the New England Journal Medicine. The first of these studies conducted in Europe focused on people who were resuscitated 5-15 minutes after collapse. Patients participating in this study experienced spontaneous return of circulation (ROSC) after an average of 105 minutes. Subjects were then cooled over a 24 hour period, with a target temperature of 32-34°C (89.6-93.2°F). 55% of the 137 patients in the hypothermia group experienced favorable outcomes, compared with only 39% in the group that received standard care following resuscitation.^[4] Death rates in the hypothermia group were 14% lower, meaning that for every 7 patients treated one life was saved.^[4] Notably, complications between the two groups did not differ substantially. This data was supported by another similarly run study that took place simultaneously in Australia. In this study 49% of the patients treated with hypothermia following cardiac arrest experienced good outcomes, compared to only 26% of those who received standard care.^[5]

Stroke

Most of the data concerning hypothermia’s effectiveness in treating stroke is limited to animal studies. These studies have focused primarily on ischemic as opposed to hemorrhagic stroke, as hypothermia is associated with a lower clotting threshold. In these animal studies, hypothermia represented an effective all purpose neuroprotectant.^[6]This promising data has lead to the initiation of human studies. Unfortunately, at the time of this article’s publishing, no results have yet been returned. In terms of feasibility, however, the use of hypothermia to control intracranial pressure (ICP) after an ischemic stroke was found to be both safe and practical.^[7] In 2008, long-term hypothermia induced by low-dose hydrogen sulfide, a weak, reversible inhibitor of oxidative phosphorylation, was shown to reduce the extent of brain damage caused by ischemic stroke in rats.^[8]

Fever

The effects of elevated body temperature following cardiac arrest, stroke, and brain trauma are surprisingly pronounced. According to one study, elevated body temperature correlated strongly with an extended stay in the ICU for patients suffering from either brain ischemia or brain trauma.^[9] Another paper stated that those suffering from either brain trauma or brain ischemia that entered the ICU with a fever had a 14% higher mortality rate than normothermic patients.^[10] It appears that the ischemic or traumatized brain is particularly susceptible to the damaging influence of elevated temperature. Combating fever through the use of temperature dampening devices represents a critical aspect of neurological care.^[11]

Cellular mechanism

Faced with this extensive array of clinical data, many scientists have attempted to explain the cellular processes responsible for the therapeutic effect of hypothermia following a blockage of blood flow to the brain. The earliest explanations for why hypothermia acted as a neuroprotectant focused on the slowing of cellular metabolism resultant from a drop in body temperature. For every drop in body temperature of a degree Celsius cellular metabolism slows by 5-7%.^[10] Because of this reality, most early theorists believed that hypothermia lessened the harmful effects of oxygen deprivation by decreasing the body’s need for oxygen.^[1] The initial emphasis on cellular metabolism explains why the early studies almost exclusively focused on the application of deep hypothermia, as these researchers believed that the therapeutic effects of hypothermia correlated directly with the extent of temperature decline.^[12]

More recent data shows that even a modest reduction in temperature can function as a neuroprotectant. This seems to suggest that hypothermia works on pathways that extend beyond mere metabolism. So while current researchers do not dismiss the fact that cellular metabolism plays a part in the therapeutic value of hypothermia, most have looked for other pathways in hopes of explaining hypothermia’s ability to act as a neuroprotectant.

One of the most promising explanations centers around the series of reactions that occur following oxygen deprivation, particularly those concerning ion homeostasis. In truth, cell death is not caused by oxygen deprivation directly, but rather the cascade of reactions that oxygen deprivation leads to. Cells need oxygen to create ATP--a molecule used by cells to store energy--and cells need ATP to regulate cellular ion levels. Simply, cells use ATP to fuel both the importation of ions necessary for cellular function and the removal of ions that are harmful to cellular function. Without oxygen, cells cannot manufacture the necessary ATP to regulate ion levels and thus cannot prevent the intercellular environment from approaching the ion concentration of the outside environment. It is not oxygen deprivation itself that precipitates cell death, but rather the disruption of homeostasis resultant from oxygen deprivation that leads to cellular apoptosis.^[1]

Getting back to hypothermia, it is notable that even a small drop in temperature encourages cell membrane stability during periods of oxygen deprivation. For this reason, a drop in body temperature helps prevent an influx of unwanted ions during an ischemic insult. By making the cell membrane more impermeable, hypothermia helps prevent the cascade of reactions set off by oxygen deprivation. Even moderate dips in temperature strengthen the cellular membrane, helping to minimize any disruption to the cellular environment. It is by moderating the disruption of homeostasis caused by a blockage of blood flow that many now postulate results in hypothermia’s ability to minimize the trauma resultant from ischemic injuries.^[1]

The therapeutic effect of hypothermia does not confine itself to metabolism and membrane stability. Another school of thought focuses on hypothermia’s ability to prevent the injuries that occur after circulation returns to the brain, or what is termed reperfusion injuries. An individual suffering from an ischemic insult continues suffering injuries well after circulation is restored. In rats it has been shown that neurons often die a full 24 hours after blood flow returns.^[13] Some theorize that this delayed reaction derives from the various inflammatory immune responses that occur during reperfusion. These inflammatory responses cause intracranial pressure, pressure which leads to cell injury and in some situations cell death. Hypothermia has been shown to help moderate intracranial pressure and therefore to minimize the harmful effect of a patient’s inflammatory immune responses during reperfusion. Beyond this, reperfusion also increases free radical production. Many now suspect it is because hypothermia reduces both intracranial pressure and free radical production that hypothermia improves patient outcome following a blockage of blood flow to the brain.^[1]

Mechanics

When discussing therapeutic hypothermia it is important to note the various clinical realities associated with this medical procedure. To start, time moderates hypothermia’s effectiveness as a neuroprotectant. Much of the animal data suggests that the earlier hypothermia is induced the better the subject’s outcome.^[13] However, therapeutic hypothermia remains partially effective even when initiated as long as 6 hours after collapse.^[14] Patients entering a state of induced hypothermia should also receive extensive monitoring from medical professionals. Clinicians must remain watchful of the negative side-effects associated with hypothermia. These side-effects include: arrhythmia, decreased clotting threshold, increased risk of infection, and electrolyte imbalance. The medical data suggests that these side-effects can be mitigated only if the proper protocols are followed. Importantly, medical professionals must avoid overshooting the target temperature, as hypothermia’s negative side-effects increase in prevalence the lower a patient’s body temperature drops.^[14] The accepted medical standards assert that a patient’s temperature should not fall below a threshold of 32°C (89.6°F).^[14]

Medical professionals must attempt to minimize a patient's shivering response. For human beings temperature represents one of our most tightly regulated parameters.^[3] When body temperature drops below a certain threshold--typically around 36 °C (96.8 °F)--patients will begin to shiver.^[3] It appears that regardless of technique patients begin to shiver when temperature drops below this threshold.^[3] This behavior hinders the ability of medical professionals to induce hypothermia. For this reason, hypothermia should be induced in conjunction with pharmaceuticals that prevent this reaction. The drugs most commonly employed are Desflurane and Demerol.^[3] Finally, clinicians should rewarm patients slowly and steadily in order to avoid unhealthy spikes in intracranial pressure. A patients rewarming should occur at a rate of .5-1 °C an hour in order to avoid injury.^[14] In fact, most deaths caused by therapeutic hypothermia occurred during the rewarming phase of the procedure, deaths easily avoided by slow and precise rewarming.^[15]

Methods

The medical methods through which hypothermia is induced break down into two categories: invasive and non-invasive.

Invasive

Cooling catheters

Cooling catheters control temperature through invasive internal maneuvering. The process works by inserting a catheter into the femoral vein and placing it near the heart. Once the catheter reaches the heart, a control unit governs the temperature of saline solution circulating through the catheter. The saline cools a patient’s whole body by lowering the temperature of the patient’s blood as it leaves the heart.The main advantage of cooling catheters over other cooling alternatives is their precision and speed. Catheters claim to reduce temperature at rates approaching 4 °C per hour. Through the use of a sophisticated control unit, catheters can also bring body temperature to within .1 °C of the target level. This level of accuracy allows doctors to avoid many of the pitfalls associated with excessively deep levels of hypothermia. Deriving from their precision, catheters can raise temperature at a steady rate, which helps to avoid harmful rises in intracranial pressure.^[16][17]

However, this invasive technique has been associated with bleeding, infection, vascular puncture, and deep vein thrombosis.^[15] Infection caused by cooling catheters is particularly harmful, as resuscitated patients are highly vulnerable to the complications associated with infections.^[18] Due to a decreased clotting threshold in hypothermic patients, bleeding too represents a significant danger.^[14] Yet the risk of deep vein thrombosis might be the most pressing medical complication associated with catheters. One study found that incidents of deep vein thrombosis increased by 33% if a patient’s catheter was kept active for 4 days or less and 75% if their catheter was left attached for 4 days or more.^[19] Deep vein thrombosis can be characterized as a medical event whereby a blood clot forms in a deep vein, usually the femoral vein. This condition turns deadly when the clot travels to the lungs and causes a pulmonary embolism.

Catheters, by denying doctors access to the femoral vein, also prevent the administration of other necessary medical procedures. Unlike non-invasive alternatives, application of catheters requires the attention and time of a supervising medical doctor. Finding an M.D. has been shown to delay catheter insertion by as much as 75 minutes and inserting a catheter takes doctors away from other important duties. ^[20]

Non-invasive

Water blankets

Water blankets are a technology where cold water pushes through a blanket using positive pressure. To lower temperature with optimal speed, medical professionals must cover 80% of a patient’s surface area with water blankets. These blankets are typically augmented by ice packs or cold fans in order to achieve more rapid temperature decline. This technique of temperature management dates back to the 1950’s and represents perhaps the most well studied means of controlling body temperature. Water blankets lower a patient’s temperature exclusively by cooling a patient’s skin and accordingly require no insertion of anything into the patient’s body. This is important because any medical procedure that must penetrate a patient’s skin brings with it a host of potentially deadly side-effects. Furthermore, nursing professionals can administer water blankets without a supervising M.D.^[21][22]

However, water blankets possess several undesirable qualities. First off, they are particularly susceptible to leaking and for this reason represent a serious electrical hazard.^[23] Also, water blankets are labor intensive and require near constant monitoring.^[23] Water blankets were not designed with sophisticated temperature management in mind and applying water blankets for this purpose requires large amounts of effort on the part of hospital staff. In addition to the labor required, water blankets lower body temperature at a slower rate than other cooling alternatives. Moreover, water blankets often imprecisly cool patients. Water blankets tend to overshoot the target temperature and cool patients to levels below 32 °C (89.6 °F). Hypothermia’s negative side-effects increase in prevalence the lower a patients body temperature drops, making unnecessary fluctuations in temperature detrimental to patient health.^[14] Likewise, due to their imprecision, water blankets often rewarm patients at too quick a rate. This leads to spikes in intracranial pressure, spikes that can cause serious brain injury and in some instances patient mortality.^[18]

Arctic Sun

The Arctic Sun attempts to use the non-invasive nature of water blankets and the precision and speed of catheters. This device consists primarily of a large control module and connected gel pads. The gel pads stick to a patient’s body using an adhesive called hydrogel—a substance that adheres to the skin without removing hair follicles. When cooling a patient, the Arctic Sun’s gel pads cover only 40% of a patient’s surface area and subsequently leave most of the patient’s body free for augmenting medical procedures. A control module using negative pressure circulates water through these pads at a temperature between 4-42°C (39.2-107.6°F). Water is pulled through the pads rather than pushed, which in turn minimizes the risk of leakage. By controlling the temperature of the water running through the gel pads, the Arctic Sun’s control module can effectively bring a patient’s temperature to the desired level at a rate of 1.5 °C an hour. Through the use of a computer algorithm, the Arctic Sun can achieve accuracy of .2 °C without much monitoring from medical professionals. This only little variation of the desired temperature allows for slow and methodical rewarming and prevents excessive jumps in intracranial pressure. Yet, due to the Arctic Sun’s noninvasive nature, this precision is achieved with out the host of side effects associated with invasive procedures such as cooling catheters.^[24]

A serious complaint levied against the Arctic Sun relates to the risk of skin injury. One study found that one in ten thousand patients treated with the Arctic Sun suffered from some form of skin incidence.^[18] Skin issues reported to the FDA are less than five in thousands of uses. An article recently published in a journal on resuscitation ( available at www.sciencedirect.com ) documents a severe case of actual skin removal. A letter from the lead author notes that this rare occurance could be due to other contributing factors and that he continues to use the Arctic Sun. Other researchers claim that catheters can lower body temperature at a faster rate, which is relevant because most of the clinical data suggests that the sooner cooling initiates the better a patient’s outcome. However, their exists a 75 minute delay on average between admittance and catheter insertion. The Arctic Sun can be administered much quicker by unsupervised nursing professionals.^[20] So although catheters cool at a quicker rate, because of early administration, most studies find that patients treated with the Arctic Sun reached their target temperature after roughly the same amount of time as those treated with cooling catheters.^[18]

Conclusion

The use of hypothermia for therapeutic purposes represents a technique with increasing levels of application. Virtually unknown a few decades ago, it is now part of the standard package of care for the thousands of individuals suffering from cardiac arrest every year. Yet with human studies concerning hypothermia’s effectiveness in treating ischemic stroke and brain trauma in the process of being completed, it appears that the current therapeutic uses of hypothermia represent only the tip of the iceberg.

See also

• Hypothermia
• Resuscitation
• Cardiac Arrest
• Stroke
• Neuroprotection
• Arctic Sun

External links

• New England Journal of Medicine
• The Big Chill
• Newsweek
• Why Chill
• Medivance manufacturer of Arctic Sun
• Alsius manufacturer of cooling catheters
• CSZ manufacturer of water blankets

Notes

1. ^ ^{a b c d e f g h i j} [Polderman, Kees H. “Application of therapeutic hypothermia in the ICU.” Intensive Care Med. (2004) 30:556-575. http://www.springerlink.com/content/9n1h8x2bj8vcc5b8/
2. ^ Therapeutic Hypothermia After Cardiac Arrest: An Advisory Statement by the Advanced Life Support Task Force of the International Liaison Committee on Resuscitation - Nolan et ...
3. ^ ^{a b c d e} Sessler, Daniel. “Thermoregulation and Heat Balance.” Therapeutic Hypothermia. Ed. Mayer, Stephen and Sessler, Daniel. Marcel Decker: New York, 2005.
4. ^ ^{a b} Holzer, Michael. “Mild Hypothermia to Improve the Neurologic Outcome After Cardiac Arrest.” New England Journal of Medicine. (2002) Vol. 346, No. 8.
5. ^ Bernard, Stephen et al. "Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia." New England Journal of Medicine. (2002) Vol. 346, No. 8. http://content.nejm.org/cgi/content/abstract/346/8/557
6. ^ Krieger, Derk. et al.“Cooling for Acute Ischemic Brain Damage.” American Heart Association. May 25, 2001, pg. 1847-1854
7. ^ Schwab, S. et. al. “Moderate Hypothermia in the Treatment of Patients with Severe Middle Cerebral Artery Infarction.” American Heart Association. July 31, 1998, pg. 2461-2466 http://cat.inist.fr/?aModele=afficheN&cpsidt=1604537
8. ^ Florian B, Vintilescu R, Balseanu AT, Buga A-M, Grisk O, Walker LC, Kessler C, Popa-Wagner A (2008). "Long-term hypothermia reduces infarct volume in aged rats after focal ischemia". Neuroscience Letters 438: 180-185. PMID 18456407. 
9. ^ Dringer, Michael et al. “Elevated body temperature independently to increased length of stay in neurological intensive care unit patients.” Critical Care Medicine. 2004 Vol. 32, No. 7, pg. 1489-1495
10. ^ ^{a b} Kammersgaard, L.P. et al. “Admission Body Temperature Predicts Long-Term Mortality After Acute Stroke http://stroke.ahajournals.org/cgi/content/abstract/33/7/1759.” American Heart Association. March 12, 2002, pg. 1759-1762.
11. ^ Ginsberg, Myron et al. “Combating Hyperthermia in Acute Stroke.” American Association. November 10, 1997, pg. 529-534. http://stroke.ahajournals.org/cgi/content/abstract/29/2/529
12. ^ Polderman, Kees. “Induced hypothermia and fever control for prevention and treatment of neurological injuries.” Lancet. 2008; 371: 1955–69. http://www.tripdatabase.com/spider.html?itemid=714708
13. ^ ^{a b} Adler, Jerry. “Back From the Dead.” Newsweek. July 23, 2007. http://www.accessmylibrary.com/coms2/summary_0286-32455420_ITM
14. ^ ^{a b c d e f} Calver, Patty. “The Big Chill.” RN. (2005) Vol. 68, No. 5 http://rn.modernmedicine.com/rnweb/article/articleDetail.jsp?id=158219
15. ^ ^{a b} Schwab, Stefan et al. “Feasibility and Safety of Moderate Hypothermia After Massive Hemisphere Infarction.” American Heart Association. June 4, 2001, pg. 2033-2035.
16. ^ Products: Alsius.com
17. ^ Products
18. ^ ^{a b c d} Haugk, Moritz et al. “Feasibility and efficacy of new non-invasive cooling device in post resuscitation intensive care medicine.” Resuscitation (2007 75, 76-81. http://www.ncbi.nlm.nih.gov/pubmed/17462808?dopt=Abstract
19. ^ Simosa, Hector et al. “Increased Risk of Deep Venous Thrombosis with Endovascular Cooling in Patients with Traumatic Head Injury." Southeastern The American Surgeon, Volume 73, Number 5, May 2007 , pp. 461-464(4). http://www.ingentaconnect.com/content/sesc/tas/2007/00000073/00000005/art00008;jsessionid=ync1aosgzxe0.alexandra?format=print
20. ^ ^{a b} (Sterz-Dept of Emergency Medicine, Medical University of Vienna March 2007)
21. ^ CSZ - What We Do
22. ^ Gaymar Industries, Inc. - Temperature Therapy Management
23. ^ ^{a b} Holden, Mary et al. "Clinically Induced Hypothermia: Why Chill Your Patient?" Advanced Critical Care. (2006) Vol. 17, No. 2, pg. 125-132. http://www.ncbi.nlm.nih.gov/pubmed/16767013
24. ^ Medivance

Wikipedia content modification information:

• This page was last modified on 29 August 2008, at 05:00.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Therapeutic hypothermia".

The URL for this specific entry is:

• http://medlibrary.org/medwiki/Therapeutic_hypothermia

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.